Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified is the 242nd most traded HS4 level product.

In 2025, the top partners where Estonia exported Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified to were Latvia (€6.2M), Lithuania (€2.14M), Germany (€1.28M), Russian Federation (€883k), and United States of America (€295k). During the same period, Estonia imported Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified from Germany (€31M), Lithuania (€25.2M), Poland (€18M), Switzerland (€17.8M), and Slovenia (€15.6M).

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified is a 4 digit product (HS4 ID 3002).